Individual Effects of Liraglutide on Cardiorenal Risk Markers: Results from the LEADER Trial

Research output: Contribution to journalConference abstract in journalResearchpeer-review

  • Frederik Persson
  • Emilie Hein Zobel
  • Tine Hansen
  • Soren Rasmussen
  • Bernt Johan von Scholten
  • Benjamin Wolthers
  • Rossing, Peter
Original languageEnglish
Article numberPUB071
JournalJournal of the American Society of Nephrology
Volume30
Issue numberKidney Week Edition
Number of pages2
ISSN1046-6673
Publication statusPublished - 2019

ID: 239211348